Apolipoprotein E4 (APOE4) is associated with a greater response to neuroinflammation and the risk of developing late-onset Alzheimer’s disease (AD). Findings implicate greater activation of cPLA2 signaling system with APOE4, which could represent a potential drug target for mitigating… User space3130, in the apoe4info subreddit, 19 Jun 2022